Patents for C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749) |
---|
10/02/2008 | WO2008097640A3 Triazole compounds that are useful in the treatment of proliferative disorders, such as cancer |
10/02/2008 | WO2007139968A3 Triazole compounds that modulate hsp90 activity |
10/02/2008 | US20080242860 Silver halide color photographic light-sensitive material and image formation method using the same, silver halide emulsion, reducing compound having group adsorptive to silver halide and method for producing the same |
10/02/2008 | US20080242656 N-Substituted-N-Sulfonylaminocyclopropane Compounds and Pharmaceutical Use Thereof |
10/02/2008 | US20080241591 Organic electroluminescence device and phenylenediamine derivative |
10/01/2008 | EP1975157A1 METHOD FOR PRODUCTION OF HETEROAROMATIC RING COMPOUND HAVING N-Rf GROUP |
10/01/2008 | EP1973890A2 Indane modulators of glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof |
10/01/2008 | EP1565456B1 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same |
10/01/2008 | EP1372655B1 Cathepsin cysteine protease inhibitors |
10/01/2008 | CN101273988A Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substituted amino 1,2,3-triazoles |
10/01/2008 | CN100421663C Imidazo (4,3-e)-1,2,4-triazolo(1,5-c) pyrimidines as adenosine A2A receptor antagonists |
09/30/2008 | CA2355470C Benzoheterocycles and their use as mek inhibitors |
09/30/2008 | CA2314009C Triazole and imidazole derivatives |
09/25/2008 | WO2008115154A1 Catalyst immobilization on siliceous mesocellular foam via click chemistry |
09/25/2008 | US20080234481 Forming salts such as tartrate or mandelate ; chemical intermediate |
09/25/2008 | US20080234278 Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions |
09/25/2008 | US20080234252 2-[4-(4-Chlorophenyl)-5-(methoxymethyl)-4H-1,2,4-triazol-3-yl]isoindoline; vasopressin antagonists; dysmenorrhea, Alzheimer's disease, anorexia nervosa, anxiety, anxiety disorder, asthma, atherosclerosis, autism, cardiovascular disease |
09/24/2008 | CN101273021A Selected CGRP antagonists, methods for the production thereof and their use as medicaments |
09/23/2008 | US7427612 Such as 1-(4-{4-[2-(cyclopropylmethyl-amino)-5-nitro-benzoyl]-piperazin-1-yl}-3-fluoro- phenyl)-ethanone for treatment of psychoses, pain, neurodegenerative disfunction in memory and learning, schizophrenia, dementia, attention deficit disorders, or Alzheimer's disease |
09/17/2008 | EP1791825B1 Benzoyl-substituted serine amides |
09/17/2008 | EP1392639B1 Pyruvate derivatives |
09/17/2008 | EP1272827B1 Analyte detection |
09/17/2008 | CN100418956C Process for preparation of aryltriazolinones |
09/17/2008 | CN100418951C Cycloamine derivative and its use as medicine |
09/16/2008 | US7425555 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
09/12/2008 | WO2008107322A1 Indole, benzimidazole or benzotriazole derivatives including a piperidine or piperazine core as anti-neoplasic agents or cell proliferation inhibitors |
09/12/2008 | WO2008075955A3 Process for the preparation of 1,4,5-trisubstituted triazoles and 3,4,5-trisubstituted triazoles |
09/12/2008 | WO2008073461A3 Ion channel modulators |
09/12/2008 | WO2007134678A3 Triazole derivatives ii |
09/11/2008 | US20080221675 Functionalized phosphine oxide photoinitiators having an attached benzotriazole or hydroxyphenylbenzotriazole ring; capable of initiating free radical polymerization; contact and intraocular lenses |
09/10/2008 | EP1966282A1 Polymer structure reacting with keratin, synthesis and use thereof |
09/10/2008 | EP1966167A1 Diaryltriazolmethylamine derivatives, preparation and therapeutic use thereof |
09/10/2008 | EP1966166A1 1,2,4-TRIAZOL-l-YL BISPHENYL DERIVATIVES FOR USE IN THE TREATMENT OF ENDOCRINE-DEPENDENT TUMOURS |
09/10/2008 | EP1965644A1 Novel herbicides |
09/10/2008 | EP1362856B1 Water-soluble triazole fungicide |
09/10/2008 | CN101260081A Preparation method for N-arylazoles compounds |
09/04/2008 | WO2008105607A1 Heteroaryl-imidazole derivatives as cannabinoid cb1 receptor antagonists |
09/04/2008 | WO2008104203A2 18f fluoro-benzoyl labelled biological active coumpounds as diagnositic imaging agents as well as benzotriazol-1-yloxy-benzoyl, 2,5-dioxo-pyrrolidin-1-yloxy) benzoyl and trimethylammonio-benzoyl precursers |
09/04/2008 | US20080214831 Copper-catalysed ligation of azides and acetylenes |
09/04/2008 | US20080214673 e.g. Furan-3-carboxylic acid [(1R,3R)-3-(3-chloro-phenylethynyl)-3-hydroxy-cyclohexyl]-amide; metabotropic glutamate receptors modulator/antagonist;anxiolytic agent, antidepressant; amidation of amine-compounds |
09/04/2008 | US20080214622 Substituted Triazole Derivatives As Oxytocin Antagonists |
09/04/2008 | US20080214532 Carboxanilides as Microbiocides |
09/04/2008 | US20080214448 Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist Peptide |
09/04/2008 | CA2679514A1 18f fluoro-benzoyl labelled biologically active compounds as diagnostic imaging agents as well as benzotriazol-1-yloxy-benzoyl, 2,5-dioxo-pyrrolidin-1-yloxy-benzoyl and trimethylammonio-benzoyl precursers |
09/03/2008 | EP1964848A1 Radiofluorination methods |
09/03/2008 | EP1962864A1 Antibacterial agents |
09/02/2008 | US7420089 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition |
09/02/2008 | US7420062 Hetaryl-substituted pyrazolidindione derivatives with pesticidal characteristics |
09/02/2008 | US7419513 Benzotriazole/HALS molecular combinations and compositions stabilized therewith |
08/28/2008 | WO2008103353A1 Triazole compounds that modulate hsp90 activity |
08/28/2008 | WO2008060931A3 Method for preparing fluorinated benzotriazole compounds |
08/28/2008 | WO2007133820A3 Diaryl triazolones as cb1 antagonists |
08/28/2008 | US20080207915 Reacting 3,5-bis(halmethyl)toluene with metal cyanide; cyanation in presence of catalyst; methylation with methyl iodide; heating with sodium or potassium salt of 1,2,4-triazole |
08/28/2008 | CA2678846A1 Peroxisome proliferator activated receptor modulators |
08/27/2008 | EP1960352A1 2-adamantylurea derivatives as selective 11beta-hsd1 inhibitors |
08/27/2008 | EP1455781B1 Use of anastrozole for the treatment of post-menopausal women having early breast cancer |
08/27/2008 | CN101253160A Improved process for the preparation of letrozole |
08/27/2008 | CN101250163A Process for producing epoxytriazole compound and intermediate therefor |
08/26/2008 | US7417151 Boron-based organic cations and related methods |
08/26/2008 | CA2329230C A process for the manufacture of sulfonylaminocarbonyl triazolinones in the presence of xylene as solvent |
08/21/2008 | WO2008098798A1 Tetrahydronaphthalenylamides, a process for their production and their use as anti-inflammatory agents |
08/21/2008 | WO2007139955A3 Triazole compounds that modulate hsp90 activity |
08/21/2008 | US20080200551 Flourene Derivative |
08/21/2008 | US20080200528 Derivatives of a 1-Phenyltriazole |
08/21/2008 | US20080200519 5-Amino-1-(4-fluorophenyl)-N-[6-fluoro-1,2,3,4-tetrahydro-2-hydroxy-5-methoxy-4,4-dimethyl-2-(trifluoromethyl)naphthalene-1-yl]-1H-pyrazole-4-carboxamide; selectivity to glucocorticoid receptor; fewer side effect; inhibit secretion of cytokine IL-8 into monocyte cell line THP-1 triggered by lipopolysacch |
08/21/2008 | US20080200518 insecticides, acaricides; crops, foods and goods; a urea, a thiourea or a guanidine; ring is imidazole or 1,2,4-triazole or tetrazole; 4-{4-[4-(3,3-Dichloroprop-2-enyloxy)-2,6-dichlorophenoxy]butyl}-1-[4-(trifluoromethyl)phenyl]-1,2,4-triazolin-5-one; a 1,2,3,4-tetrazolin-5-one |
08/21/2008 | US20080200462 Substituted pyrazole and triazole compounds as ksp inhibitors |
08/20/2008 | EP1958934A1 Tetrahydronaphthalenylamides, a process for their production and their use as anti-inflammatory agents |
08/20/2008 | EP1957459A2 Iminopropene compound and use thereof |
08/19/2008 | US7414134 B1 bradykinin receptor antagonists |
08/14/2008 | WO2008097640A2 Triazole compounds that are useful in the treatment of proliferative disorders, such as cancer |
08/14/2008 | US20080194656 Benzotriazole Derivatives as Cannabinoid Receptor Antagonists |
08/14/2008 | CA2677481A1 Triazole compounds that modulate hsp90 activity |
08/13/2008 | CN101239932A Preparation of 3,5-di(2-cyano-isopropyl)-toluene |
08/12/2008 | US7411098 Aldol condensation of citral with acetone and subsequent hydrogenation; using tetrahydrogeranylacetone for preparing phytol, isophytol, tocopherol and/or tocopherol derivatives |
08/12/2008 | US7410933 Substituted thiene-3-ylsulphonylamino(thio)carbonyl-triazolin(thi)ones |
08/07/2008 | WO2008094617A2 Crystalline forms of deferasirox |
08/07/2008 | WO2008076225A3 Non-nucleoside reverse transcriptase inhibitors |
08/07/2008 | US20080188490 e.g. 1-(3-Chloro-phenylethynyl)-3-(3,4-difluoro-phenylamino)-cyclohexanol; metabotropic glutamate receptors modulator/antagonist; |
08/07/2008 | US20080188474 Substituted triazoles useful as axl inhibitors |
08/07/2008 | US20080188455 angiogenesis and/or cell proliferation, carcinoma, myeloid leukemia, endometriosis; inhibitors of the receptor protein tyrosine kinase; N3-(3-cyclopentyl-1,2,3,4,5,6-hexahydrobenzo[d]azocin-8-yl)-1-(6-fluoroquinazolin-4-yl)-1H-1,2,4-triazole-3,5-diamine |
08/07/2008 | US20080187978 Anti-inflammatory medicaments |
08/07/2008 | DE102007004698A1 Verbindungen enthaltend Organofluorochlorophosphatanionen Compounds containing Organofluorochlorophosphatanionen |
08/07/2008 | DE102006053594B4 Verfahren zur Reinigung von Letrozol A process for purifying letrozole |
08/06/2008 | EP1951690A1 Heterocyclic cetp inhibitors |
08/06/2008 | EP1951689A1 P2x7 receptor antagonists and methods of use |
08/06/2008 | EP1485088B1 Opioid receptor active 4-(3-hydroxyphenyl) or 4-(3-alkoxyphenyl)-1,2,4-triazole compounds |
08/06/2008 | EP1439169B1 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor |
08/06/2008 | CN100408036C Use of anastrozole for the treatment of post-menopausal women having early breast cancer |
08/05/2008 | US7407974 e.g. 4-Methoxy-pyrrolidine-1,2-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 2-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide}; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease |
08/05/2008 | US7407972 e.g. 4,5-Dihydro-pyrazole-1,5-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 5-[(3-fluoro-2'-methanesulfonyl-biphenyl-4-yl)-amide]; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease |
08/05/2008 | US7407516 variety of molecules used as oxidation bases and couplers allows a wide range of colors to be obtained; hair dye |
08/05/2008 | CA2337586C Alkylation process and novel hydroxyphenylbenztriazoles |
07/31/2008 | WO2008090565A1 Novel thermodynamically stable polymorphic form-l of letrozole |
07/31/2008 | WO2008057775A3 Heterocyclic amide compounds useful as kinase inhibitors |
07/31/2008 | WO2006135627A3 Inhibitors of akt activity |
07/31/2008 | US20080182862 e.g. 1-(isoquinolin-1-yl)-N3-(2-(pyrrolidin-1-ylmethyl)benzo[d]oxazol-5-yl)-1H-1,2,4-triazole-3,5-diamine; protein tyrosine kinase receptor Axl inhibitor; bioassay; antiinflammatory, anticarcinogenic agent, anticoagulant; rheumatoid arthritis, vascular disease, diabetic retinopathy, osteoporosis |
07/31/2008 | US20080182857 Heat Shock Protein 90 inhibitors; 5-(2,4-dihydroxyphenyl)-4-(naphth-1-yl)-4H-1,2,4-triazole-3-thiol; incorrect protein folding or aggregation; hydrazonederivatives react with dimiadazole cabonyl/thiocarbonyl derivatives; hydrazines derivatives react with isocyanate or isothiocyanates; tumors, cancer |
07/31/2008 | US20080182837 New chemical compounds |
07/30/2008 | CN101233100A An impurity of anastrozole intermediate, and uses thereof |